Murray Mark J. 4
4 · Arbutus Biopharma Corp · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Murray Mark J.
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-03-01+357,500→ 357,500 totalExercise: $4.57Exp: 2029-03-01→ Common Shares (357,500 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable in three equal annual installments beginning March 1, 2020.